U.S. Physical Therapy Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de U.S. Physical Therapy han disminuido a una tasa media anual de -9.9%, mientras que en la industria Healthcare los beneficios crecieron en un 7.2% anualmente. Los ingresos han ido creciendo a una tasa media de 8% al año. La rentabilidad financiera de U.S. Physical Therapy es de 4.7%, y sus márgenes netos son de 2.2%.

Información clave

-9.9%

Tasa de crecimiento de los beneficios

-11.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	15.7%
Tasa de crecimiento de los ingresos	8.0%
Rentabilidad financiera	4.7%
Margen neto	2.2%
Última actualización de beneficios	30 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero U.S. Physical Therapy. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

DB:UPH Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Sep 24	639	14	57
30 Jun 24	621	16	54
31 Mar 24	606	18	52
31 Dec 23	599	18	52
30 Sep 23	585	24	50
30 Jun 23	575	26	50
31 Mar 23	564	28	48
31 Dec 22	548	29	46
30 Sep 22	536	39	45
30 Jun 22	522	38	46
31 Mar 22	509	37	47
31 Dec 21	490	31	47
30 Sep 21	477	31	47
30 Jun 21	461	30	44
31 Mar 21	418	32	41
31 Dec 20	418	32	42
30 Sep 20	423	30	43
30 Jun 20	431	31	43
31 Mar 20	473	29	45
31 Dec 19	477	31	45
30 Sep 19	472	30	44
30 Jun 19	468	23	44
31 Mar 19	457	18	42
31 Dec 18	449	17	41
30 Sep 18	442	18	41
30 Jun 18	432	22	39
31 Mar 18	421	21	38
31 Dec 17	410	22	36
30 Sep 17	392	20	34
30 Jun 17	377	20	33
31 Mar 17	363	21	32
31 Dec 16	353	21	32
30 Sep 16	348	20	34
30 Jun 16	344	21	33
31 Mar 16	337	21	32
31 Dec 15	327	21	31
30 Sep 15	320	21	30
30 Jun 15	313	20	31
31 Mar 15	308	20	31
31 Dec 14	301	19	30
30 Sep 14	290	19	29
30 Jun 14	278	18	28
31 Mar 14	267	18	27
31 Dec 13	260	18	26

Ingresos de calidad: UPH tiene una única gran pérdida de $28.5M que afecta a sus resultados financieros de los últimos 12 meses de 30th September, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(2.2%) de UPH son inferiores a los del año pasado (4.1%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de UPH han disminuido en un 9.9% al año en los últimos 5 años.

Acelerando crecimiento: UPH ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: UPH tuvo un crecimiento negativo de los beneficios (-40.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (40.5%).

U.S. Physical Therapy Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Recent updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock

Independent Director recently bought €54k worth of stock

Second quarter 2022 earnings released: EPS: US$0.86 (vs US$0.82 in 2Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 16, 2022

U.S. Physical Therapy, Inc. to Report Q2, 2022 Results on Aug 04, 2022

First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.21 in 1Q 2021)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on June 14, 2022

Insufficient new directors

U.S. Physical Therapy, Inc. to Report Q1, 2022 Results on May 05, 2022

U.S. Physical Therapy, Inc., Annual General Meeting, May 17, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in Madden and Gilbert Physical Therapy, LP from Chad Madden, Michael Gilbert and others for $11.5 million.